The 'ChatGPT for doctors,' OpenEvidence, was valued at $15 billion in a new funding round (www.businessinsider.com)

OpenEvidence, an AI-driven search engine specifically designed for healthcare professionals, has raised $250 million in a new funding round, bringing its valuation to an impressive $15 billion. This Miami-based startup, which has quickly become a vital tool for physicians—claimed to be the fastest-growing application in medical history—has managed to secure over $1 billion in investments from prominent firm Andreessen Horowitz and other major players in the tech industry. Over two-thirds of U.S. doctors currently utilize OpenEvidence for diagnostic and treatment advice, highlighting its significance in the health tech landscape. The newfound valuation and funding come at a crucial time as heavyweights like OpenAI and Anthropic are intensifying their focus on developing direct healthcare innovations. OpenEvidence’s established user base and partnerships with big tech companies like Nvidia, Google, and Microsoft position it as a potential acquisition target, which could streamline access to vital AI infrastructure amidst rising anti-AI sentiments that may hinder future data center expansion. As the AI landscape sees an uptick in mergers and acquisitions, the advancements and widespread adoption of OpenEvidence not only underscore the increasing importance of AI in medicine but also reflect a competitive environment among AI companies seeking to dominate this lucrative market.